REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$11.67 USD
-0.02 (-0.17%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $11.69 +0.02 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -1.16 |
EPS Last Quarter | -1.05 |
Last EPS Surprise | 18.60% |
ABR | 1.09 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.66 |
Next Year | -1.72 |
EPS (TTM) | -5.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 20.27M | 19.50M | 79.98M | 276.56M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 23.30M | 23.00M | 86.90M | 297.80M |
Low Estimate | 15.00M | 15.00M | 67.90M | 260.00M |
Year ago Sales | 28.91M | 22.21M | 90.24M | 79.98M |
Year over Year Growth Est. | -29.90% | -12.20% | -11.37% | 245.78% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.16 | -1.19 | -4.66 | -1.72 |
# of Estimates | 3 | 3 | 4 | 5 |
Most Recent Consensus | -1.28 | -1.29 | -4.99 | -2.63 |
High Estimate | -1.09 | -1.10 | -4.31 | -0.24 |
Low Estimate | -1.28 | -1.29 | -4.99 | -2.63 |
Year ago EPS | -1.41 | -1.43 | -6.02 | -4.66 |
Year over Year Growth Est. | 17.73% | 16.78% | 22.59% | 63.09% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.16 | -1.19 | -4.66 | -1.72 |
7 Days Ago | -1.16 | -1.19 | -4.66 | -1.72 |
30 Days Ago | -1.16 | -1.19 | -4.66 | -1.72 |
60 Days Ago | -1.29 | -1.21 | -5.09 | -2.94 |
90 Days Ago | -1.29 | -1.21 | -5.09 | -2.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.16 | -1.19 | -4.66 | -1.72 |
Zacks Consensus Estimate | -1.16 | -1.19 | -4.66 | -1.72 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.05 | -1.38 | -1.43 | -1.41 | NA |
Estimate | -1.29 | -1.28 | -1.27 | -1.44 | NA |
Difference | 0.24 | -0.10 | -0.16 | 0.03 | 0.00 |
Surprise | 18.60% | -7.81% | -12.60% | 2.08% | 0.07% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more